Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SARL PHARMACIE DE PLUGUFFAN : revenue, balance sheet and financial ratios

SARL PHARMACIE DE PLUGUFFAN is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PLUGUFFAN (29700), this company of category PME shows in 2015 a revenue of 914 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL PHARMACIE DE PLUGUFFAN (SIREN 531631620)
Indicator 2020 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C N/C 913 559 €
Net income 71 512 € 55 454 € 87 502 € 75 645 € 68 629 € 38 192 €
EBITDA N/C N/C N/C N/C N/C 50 174 €
Net margin N/C N/C N/C N/C N/C 4.2%

Revenue and income statement

In 2020, SARL PHARMACIE DE PLUGUFFAN generates positive net income of 72 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2020: 38 k€ -> 72 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

71 512 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 278%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

278.308%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

23.777%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.0%

Solvency indicators evolution
SARL PHARMACIE DE PLUGUFFAN

Sector positioning

Debt ratio
278.31 2020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average

In 2020, the debt ratio of SARL PHARMACIE DE PLUGUFFAN (278.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
23.78% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Average

In 2020, the financial autonomy of SARL PHARMACIE DE PLUGUFFAN (23.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 130.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

130.912

Liquidity indicators evolution
SARL PHARMACIE DE PLUGUFFAN

Sector positioning

Liquidity ratio
130.91 2020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Watch

In 2020, the liquidity ratio of SARL PHARMACIE DE PLUGUFFAN (130.91) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL PHARMACIE DE PLUGUFFAN

Positioning of SARL PHARMACIE DE PLUGUFFAN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of SARL PHARMACIE DE PLUGUFFAN is estimated at 1 010 654 € (range 673 890€ - 1 363 645€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
673k€ 1010k€ 1363k€
1 010 654 € Range: 673 890€ - 1 363 645€
NAF 5 année 2020

Valuation method used

Net Income Multiple
71 512 € × 14.1x = 1 010 655 €
Range: 673 890€ - 1 363 646€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SARL PHARMACIE DE PLUGUFFAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SARL PHARMACIE DE PLUGUFFAN

What is the revenue of SARL PHARMACIE DE PLUGUFFAN ?

The revenue of SARL PHARMACIE DE PLUGUFFAN in 2015 is 914 k€.

Is SARL PHARMACIE DE PLUGUFFAN profitable?

Yes, SARL PHARMACIE DE PLUGUFFAN generated a net profit of 72 k€ in 2020.

Where is the headquarters of SARL PHARMACIE DE PLUGUFFAN ?

The headquarters of SARL PHARMACIE DE PLUGUFFAN is located in PLUGUFFAN (29700), in the department Finistere.

Where to find the tax return of SARL PHARMACIE DE PLUGUFFAN ?

The tax return of SARL PHARMACIE DE PLUGUFFAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL PHARMACIE DE PLUGUFFAN operate?

SARL PHARMACIE DE PLUGUFFAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.